887764-14-9

Basic information

• Product Name: dithiobenzoic Acid 1-cyano-1-methyl-4-oxo-4-(2-thioxothiazolidin-3-yl)butyl ester
• Synonyms: dithiobenzoic Acid 1-cyano-1-methyl-4-oxo-4-(2-thioxothiazolidin-3-yl)butyl ester
• CAS NO: 887764-14-9
• Molecular Weight: 380.58
• Mol File: 887764-14-9.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: dithiobenzoic Acid 1-cyano-1-methyl-4-oxo-4-(2-thioxothiazolidin-3-yl)butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: dithiobenzoic Acid 1-cyano-1-methyl-4-oxo-4-(2-thioxothiazolidin-3-yl)butyl ester(887764-14-9)
• EPA Substance Registry System: dithiobenzoic Acid 1-cyano-1-methyl-4-oxo-4-(2-thioxothiazolidin-3-yl)butyl ester(887764-14-9)

Safety Data

• Hazardous Substances Data: 887764-14-9(Hazardous Substances Data)

Upstream product

• 134469-06-0 thiazolidine-2-thione 
• 201611-92-9 4-cyano-4-(thiobenzoylthio)pentanoic acid 
• 5873-93-8 bis(thiobenzoyl) disulfide 
• 870779-03-6 2-[1-cyano-1-methyl-4-oxo-4-(2-thioxo-thiazolidin-3-yl)-butylazo]-2-methyl-5-oxo-5-(2-thioxothiazolidin-3-yl)-pentanenitrile 

Downstream Products

• 1259437-57-4 2-(4-cyano-4-((phenylcarbonothioyl)thio)pentanamido)ethyl 4-(pyren-1-yl)butanoate 
• 1186665-00-8 5-(bis(2-hydroxyethyl)amino)-2-cyano-5-oxopentan-2-yl benzodithioate 
• 1202708-43-7 C₂₃H₂₈Br₂N₂O₅S₂ 

Relevant articles and documents

Synthesis of well-defined photo-cross-linked polymeric nanocapsules by surface-initiated raft polymerization

Narrowly distributed hollow polymeric nanocapsules (PtBMA-co-PDMIPM-b- PHPMA), with the size of 450 or 900 nm, were first synthesized by surface-initiated reversible addition-fragmentation chain transfer (RAFT) polymerization exploiting silica nanoparticl

COMPOSITIONS AND METHODS OF MANUFACTURING STAR POLYMERS FOR LIGAND DISPLAY AND/OR DRUG DELIVERY

A star polymer of formula O[P1]-([X]-A[P2]-[Z]-[P3])n where O is a core; A is a polymer arm attached to the core; X is a linker molecule between the core and the polymer arm; Z is a linker molecule between the end of the polymer arm and P3; P1, P2 and P3 are each independently one or more pharmaceutically active compounds that act extracellularly or intracellularly, n is an integer number; [ ] denotes that the group is optional; and at least one of P1, P2 or P3 is present.

ANTIBODY-POLYMER-DRUG CONJUGATES

Disclosed herein, are antibody-polymer-drug conjugates. The conjugate comprises a targeting moiety, one or more polymers, and one or more therapeutic agents. Also described herein, are compositions comprising the conjugates, methods of their preparation,